-
Archives
- October 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
-
Meta
Tag Archives: venlafaxine
Antidepressants can raise the risk of suicide – Sarah Knapton for the Telegraph
http://www.telegraph.co.uk/news/health/news/12126146/Antidepressants-can-raise-the-risk-of-suicide-biggest-ever-review-finds.html?utm_content=buffer3d1d3&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer We are deeply concerned at this service by the extent of public misinformation and baseless assumptions about the justification for, efficacy/side effects of and withdrawal consequences attached to these drugs – in children and adults. Many GPs appear ill informed and/or disingenuous … Continue reading →
Posted in anti-depressants, CBT, communication, consent, cultural questions, empowerment, ethics, iatrogenic illness, perception, political, psychiatric drugs, psychiatry, research evidence, risk, suicide, working with clients
|
Tagged affordable counselling exeter, aggressive behaviour, AntiDepAware, antidepressant withdrawal, antidepressants, antidepressants for children, antidepressants for teenagers, Big Pharma, Campaigns for YoungMinds, citalopram, clinical trial information on antidepressants, companies anti depressants, coping with stress, counselling, counselling exeter, counsellor Exeter, counsellors Exeter, depression, Dr Paul Ramchandani, drug trial bias, drug trial misreporting, duloxetine, Eli Lilly, emotional instability, fluoxetine, iatrogenic, iatrogenic illness, Joanna Moncrieff, Linda Foreman, low cost counselling exeter, Lucie Russell, Margaret Tisdale, Marjorie Wallace, new-generation anti-depressants, NHS guidelines, NICE guidelines, Nordic Cochrane Centre, Palace Gate Counselling Service, Palace Gate Counselling Service Exeter, paroxetine, Paul Keedwell, person centred counselling exeter, Peter Gotzsche, pharmaceutical industry, prozac, psych drug withdrawal, psychotherapy, risk of suicide, SANE, Sarah Knapton, Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, sertraline, SNRIs, SSRIs, SSRIs and suicide risk, Stephen Fry, suicidal thoughts, suicide attempts, suicide risk, talking therapy, Tarang Sharma, venlafaxine, www.palacegatecounselling.org.uk
|
Leave a comment
Palace Gate Counselling Service Blog 